Immucor, Inc. (Immucor) is a global in-vitro diagnostics company engaged in the development, production and sale of a full line of reagents and automated systems. The company develops products that are used in performing the tests to detect and identify certain properties of the cell and serum components of human blood before the process of blood transfusion. Its key customers include hospitals, clinical laboratories and blood banks. Immucor also provides fully automated instruments for daily function of blood banks, transfusion laboratories and small- and medium-sized hospitals. Its operations are concentrated in the US, Canada, Europe and Japan. The company holds 11 subsidiaries and it has manufacturing facilities in U.S. and Canada. Immucor is headquartered in Georgia, the US.